Pritzker Levine LLP、Robbins Geller Rudman & Dowd LLP、Sharp Law、LLP、Burns Charest LLP 及 Keller Rohrback L.L.P. 宣佈與被告方 Pfizer Inc. 以 $34,500 萬和解 EpiPen、EpiPen Jr. 及/或其授權仿製藥物購買者的集體訴訟 ...Middle East

PR Newswire - News
Pritzker Levine LLP、Robbins Geller Rudman & Dowd LLP、Sharp Law、LLP、Burns Charest LLP 及 Keller Rohrback L.L.P. 宣佈與被告方 Pfizer Inc. 以 $34,500 萬和解 EpiPen、EpiPen Jr. 及/或其授權仿製藥物購買者的集體訴訟
堪薩斯州堪薩斯城2021年8月5日 /美通社/ -- 以 $34,500 萬美元與 Pfizer 和解 Epinephrine Auto-Injector (EpiPen®) 的集體訴訟 有關 EPIPEN (EPINEPHRINE INJECTION, USP) MARKETING 銷售行為及反壟斷訴訟 案件編號︰2:17-md-02785-DDC-TJJ, MDL 2785(堪薩斯區) 如欲登記以獲取賠償,請瀏覽 www.EpiPenClassAction.com/fileclaim 登記資格 已支付部分或全數 EpiPen® 或 EpiPen Jr®...

Hence then, the article about pritzker levine llp robbins geller rudman dowd llp sharp law llp burns charest llp 及 keller rohrback l l p 宣佈與被告方 pfizer inc 以 34 500 萬和解 epipen epipen jr 及 或其授權仿製藥物購買者的集體訴訟 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pritzker Levine LLP、Robbins Geller Rudman & Dowd LLP、Sharp Law、LLP、Burns Charest LLP 及 Keller Rohrback L.L.P. 宣佈與被告方 Pfizer Inc. 以 $34,500 萬和解 EpiPen、EpiPen Jr. 及/或其授權仿製藥物購買者的集體訴訟 )

Apple Storegoogle play

Last updated :

Also on site :